Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Les Hôtels Baverez S.A. owns and operates three prestigious 5-star hotels in downtown Paris, France. The portfolio includes Hôtel Regina Louvre with 98 rooms and suites, a gourmet restaurant, an English pub, and a tearoom; Hôtel Raphaël featuring 83 rooms and suites along with two gourmet restaurants and an English pub; and Majestic Hôtel-Spa offering 57 rooms and apartments, a restaurant, a pub, and a spa with pool. These luxury properties provide high-end accommodations, fine dining experiences, wellness facilities, and personalized services to discerning guests seeking an elegant stay in the heart of the city. Les Hôtels Baverez S.A. focuses exclusively on the French market, catering to travelers who value historic charm, exceptional hospitality, and proximity to iconic landmarks. Founded in 1957 and headquartered in Paris, the company upholds a tradition of excellence in the luxury hospitality sector, emphasizing quality service and refined amenities within the consumer discretionary industry.
Operating margin is thin at 8.79%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 27.6% YoY. Margins deteriorated 7.4pp alongside, both lines moving the wrong way.
Free cash flow declined 870% versus the prior year, cash generation momentum has weakened. ROIC dropped from 8.26% to 3.31%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
€31M
▼ -27.6% YoY
Net Income (TTM)
€2M
▼ -48.8% YoY
Op. Margin
8.79%
▼ -7.4pp YoY
ROIC
3.31%
▼ -4.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€12M
▼ -870.4% YoY
Op. Cash Flow (TTM)
-€908K
▼ -146.1% YoY
Net Debt
-€10M
Net Cash Position
Cash & Equiv.
€28M
3Y CAGR: -7.1%
Continue Research